Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshimi Michigami

Showing results (41-50 of 137) with videos related to

Pageof 14
Sort By:
Clinical Pediatric Endocrinology : Case Reports and Clinical Investigations : Official Journal of the Japanese Society for Pediatric Endocrinology|May 3, 2014
Molecular bases of diseases characterized by hypophosphatemia and phosphaturia: new understandingKeiichi Ozono, Toshimi Michigami, Noriyuki Namba, et al.
The Journal of Biological Chemistry|December 5, 2013
Sympathetic activation induces skeletal Fgf23 expression in a circadian rhythm-dependent mannerMasanobu Kawai, Saori Kinoshita, Shigeki Shimba, et al.
Clinical and Experimental Nephrology|May 25, 2022
Factors associated with 1-year changes in serum fibroblast growth factor 23 levels in pediatric patients with chronic kidney diseaseNatsumi Yamamura-Miyazaki, Toshimi Michigami, Keiichi Ozono, et al.
European Journal of Pediatrics|January 22, 2005
Common mutations F310L and T1559del in the tissue-nonspecific alkaline phosphatase gene are related to distinct phenotypes in Japanese patients with hypophosphatasiaToshimi Michigami, Takayuki Uchihashi, Akira Suzuki, et al.
Journal of the American Society of Nephrology : JASN|June 25, 2005
Intraperitoneal administration of recombinant receptor-associated protein causes phosphaturia via an alteration in subcellular distribution of the renal sodium phosphate co-transporterMasayo Yamagata, Keiichi Ozono, Yuta Hashimoto, et al.
Bone|May 16, 2022
Growth-related skeletal changes and alterations in phosphate metabolismToshimi Michigami, Kanako Tachikawa, Miwa Yamazaki, et al.
Endocrinology|July 29, 2022
The Lack of Bmal1, a Core Clock Gene, in the Intestine Decreases Glucose Absorption in MiceShinsuke Onuma, Saori Kinoshita, Shigeki Shimba, et al.
Journal of Cellular Biochemistry|November 9, 2007
PTH/cAMP/PKA signaling facilitates canonical Wnt signaling via inactivation of glycogen synthase kinase-3beta in osteoblastic Saos-2 cellsAkira Suzuki, Keiichi Ozono, Takuo Kubota, et al.
Calcified Tissue International|November 11, 2019
Hypophosphatasia in Japan: ALPL Mutation Analysis in 98 Unrelated PatientsToshimi Michigami, Kanako Tachikawa, Miwa Yamazaki, et al.
European Journal of Pediatrics|October 14, 2015
Lethal hypophosphatasia successfully treated with enzyme replacement from day 1 after birthYoko Okazaki, Hiroyuki Kitajima, Narutaka Mochizuki, et al.
Pageof 14

Showing results (41-50 of 137) with videos related to

Sort By:
Pageof 14
Clinical Pediatric Endocrinology : Case Reports and Clinical Investigations : Official Journal of the Japanese Society for Pediatric Endocrinology|May 3, 2014
Molecular bases of diseases characterized by hypophosphatemia and phosphaturia: new understandingKeiichi Ozono, Toshimi Michigami, Noriyuki Namba, et al.
The Journal of Biological Chemistry|December 5, 2013
Sympathetic activation induces skeletal Fgf23 expression in a circadian rhythm-dependent mannerMasanobu Kawai, Saori Kinoshita, Shigeki Shimba, et al.
Clinical and Experimental Nephrology|May 25, 2022
Factors associated with 1-year changes in serum fibroblast growth factor 23 levels in pediatric patients with chronic kidney diseaseNatsumi Yamamura-Miyazaki, Toshimi Michigami, Keiichi Ozono, et al.
European Journal of Pediatrics|January 22, 2005
Common mutations F310L and T1559del in the tissue-nonspecific alkaline phosphatase gene are related to distinct phenotypes in Japanese patients with hypophosphatasiaToshimi Michigami, Takayuki Uchihashi, Akira Suzuki, et al.
Journal of the American Society of Nephrology : JASN|June 25, 2005
Intraperitoneal administration of recombinant receptor-associated protein causes phosphaturia via an alteration in subcellular distribution of the renal sodium phosphate co-transporterMasayo Yamagata, Keiichi Ozono, Yuta Hashimoto, et al.
Bone|May 16, 2022
Growth-related skeletal changes and alterations in phosphate metabolismToshimi Michigami, Kanako Tachikawa, Miwa Yamazaki, et al.
Endocrinology|July 29, 2022
The Lack of Bmal1, a Core Clock Gene, in the Intestine Decreases Glucose Absorption in MiceShinsuke Onuma, Saori Kinoshita, Shigeki Shimba, et al.
Journal of Cellular Biochemistry|November 9, 2007
PTH/cAMP/PKA signaling facilitates canonical Wnt signaling via inactivation of glycogen synthase kinase-3beta in osteoblastic Saos-2 cellsAkira Suzuki, Keiichi Ozono, Takuo Kubota, et al.
Calcified Tissue International|November 11, 2019
Hypophosphatasia in Japan: ALPL Mutation Analysis in 98 Unrelated PatientsToshimi Michigami, Kanako Tachikawa, Miwa Yamazaki, et al.
European Journal of Pediatrics|October 14, 2015
Lethal hypophosphatasia successfully treated with enzyme replacement from day 1 after birthYoko Okazaki, Hiroyuki Kitajima, Narutaka Mochizuki, et al.
Pageof 14